coads,
I'd prefer an announcement from WP on likely time frames, but in fairness to him the previous time frames have been met and I see no reason why that will not be the case in the future.
I do recall an announcement that the path to commercialisation could be four years.
In the meantime apart from a bit of confidence building for shareholders through announcements, rather than speculation, in reality the share price suggests there's not a lot to complaint about.
Ann: Updated 30-day DurAVR THV Clinical Data, page-28
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.95 |
Change
-0.250(1.30%) |
Mkt cap ! $370.7M | |||
| Open | High | Low | Value | Volume |
| $19.10 | $19.45 | $18.80 | $174.6K | 9.172K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250 | $18.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.95 | 262 | 1 |
View Market Depth
| Last trade - 11.47am 29/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |